Nuzenio

At Ionis Pharmaceuticals

At Ionis Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 9 publisher sources 100/100 entity strength

Latest news

How TRYNGOLZA Approval and New Equity Shelf At Ionis Pharmaceuticals (IONS) Has Changed Its Investment Story - simplywall.stsimplywall.st · Mon, 10 Aug 2026 11:26:56 GMTIONS Investors Have Opportunity to Join Ionis Pharmaceuticals, Inc. Fraud Investigation with SBS Law - Business WireBusiness Wire · Sat, 08 Aug 2026 20:07:00 GMTMichael Hayden Bought 34% More Shares In Ionis Pharmaceuticals - SahmSahm · Tue, 04 Aug 2026 07:00:00 GMTIonis Pharmaceuticals Director Hayden Buys $1.1 Million Shares. What Does This Mean for Investors? - The Motley FoolThe Motley Fool · Mon, 03 Aug 2026 20:17:00 GMTIonis’ top scientist Frank Bennett to retire; Recursion selects its first AI chief - Endpoints NewsEndpoints News · Fri, 31 Jul 2026 07:00:00 GMTIonis Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:IONS) 2026-07-30 - Seeking AlphaSeeking Alpha · Thu, 30 Jul 2026 07:00:00 GMTIonis Pharmaceuticals Number of Employees 2026 | Employee Count & Headcount Data - Revelio LabsRevelio Labs · Wed, 29 Jul 2026 22:34:06 GMTIonis Pharmaceuticals Inc (IONS) Q2 2026 Earnings Call Highlights: Robust Revenue Growth and ... - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Mon, 10 Aug 2026 11:26:56 GMTHow TRYNGOLZA Approval and New Equity Shelf At Ionis Pharmaceuticals (IONS) Has Changed Its Investment Story - simplywall.st
Sat, 08 Aug 2026 20:07:00 GMTIONS Investors Have Opportunity to Join Ionis Pharmaceuticals, Inc. Fraud Investigation with SBS Law - Business Wire
Tue, 04 Aug 2026 07:00:00 GMTMichael Hayden Bought 34% More Shares In Ionis Pharmaceuticals - Sahm
Mon, 03 Aug 2026 20:17:00 GMTIonis Pharmaceuticals Director Hayden Buys $1.1 Million Shares. What Does This Mean for Investors? - The Motley Fool
Fri, 31 Jul 2026 07:00:00 GMTIonis’ top scientist Frank Bennett to retire; Recursion selects its first AI chief - Endpoints News
Thu, 30 Jul 2026 07:00:00 GMTIonis Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:IONS) 2026-07-30 - Seeking Alpha

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for At Ionis Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.